← Back to all trials
Completed
NCT07931521
Clinical Trial to Evaluate the Safety and Efficacy of DW4421 in Patients With Erosive Reflux Disease
Conditions: Erosive Reflux Disease, GERD (Gastroesophageal Reflux Disease)
Sex: All
Ages: 19 Years – 74 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 328
Sponsor: Daewon Pharmaceutical Co., Ltd.
Location: The Catholic University of Korea, Incheon, St. Mary's Hospital Seoul
Summary
This study aims to compare the efficacy and safety of DW4421 to Esomeprazole in patients with Erosive Reflux Disease.
Eligibility Criteria
Inclusion Criteria:
* Adults aged 19 and older but under 75, at the time of obtaining informed consent
* Subjects endoscopically diagnosed with Grade A or higher erosive reflux disease by Los-Angeles classification within 2 weeks prior to screening
* Subjects with symptoms of heartburn and/or acid regurgitation within 1 week prior to randomization
* Subjects who are able to complete questionnaires and subject diaries during the clinical trial
Exclusion Criteria:
\[Medical history\]
* Subjects with gastrointestinal lesions at the time of screening (e.g. Barrett's esophagus)
* Subjects with a history of surgery for gastroesophageal disorders or for gastric acid suppression at the time of screening (excluding polypectomy)
* Subjects with Zollinger-Ellison Syndrome, Eosinophilic Esophagitis at the time of screening
* Subjects with a history of malignant tumor within 5 years prior to screening
* Subjects with confirmed concurrent hepatic, renal, cardiovascular, neuropsychiatric, respiratory, endocrine, or central nervous system diseases that may interfere with the evaluation of efficacy or safety in the opinion of the investigator
\[Concomitant medication use\]
* Subjects who received any of the medications specified in the protocol within 2 weeks prior to screening, or those who require continuous administration during the entire clinical trial
\[Laboratory criteria\]
-Clinically significant abnormal laboratory values during screening.
Source: ClinicalTrials.gov (NCT07931521). StuddyBuddy aggregates publicly available trial information.